Final answer:
The nurse should notify the health care provider (HCP) for the prescribed medication Terazosin for a client with BPH due to its potential side effects of orthostatic hypotension.
Step-by-step explanation:
The nurse should notify the health care provider (HCP) for the prescribed medication Terazosin for a client with benign prostatic hyperplasia (BPH). Terazosin is an alpha-blocker that is commonly used to treat BPH by relaxing the muscles in the prostate and bladder neck, making it easier to urinate. However, Terazosin can cause a common side effect known as orthostatic hypotension, which is a sudden drop in blood pressure when the client stands up or changes positions. This side effect can cause dizziness, lightheadedness, and an increased risk of falls. Therefore, it is important for the nurse to notify the HCP of this medication and discuss alternative treatment options if necessary.